nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN2A—hematopoietic system—hematologic cancer	0.0054	0.0889	CbGeAlD
Mepivacaine—SCN10A—hematopoietic system—hematologic cancer	0.00521	0.0857	CbGeAlD
Mepivacaine—SCN8A—testis—hematologic cancer	0.00427	0.0702	CbGeAlD
Mepivacaine—SCN9A—lung—hematologic cancer	0.00397	0.0654	CbGeAlD
Mepivacaine—SCN9A—testis—hematologic cancer	0.00375	0.0617	CbGeAlD
Mepivacaine—SCN2A—blood—hematologic cancer	0.00358	0.0589	CbGeAlD
Mepivacaine—SCN10A—blood—hematologic cancer	0.00345	0.0568	CbGeAlD
Mepivacaine—SCN1A—lung—hematologic cancer	0.00342	0.0562	CbGeAlD
Mepivacaine—SCN4A—testis—hematologic cancer	0.00334	0.055	CbGeAlD
Mepivacaine—SCN3A—blood—hematologic cancer	0.00314	0.0518	CbGeAlD
Mepivacaine—SCN5A—blood—hematologic cancer	0.00314	0.0516	CbGeAlD
Mepivacaine—SCN3A—bone marrow—hematologic cancer	0.00304	0.0501	CbGeAlD
Mepivacaine—SCN10A—lung—hematologic cancer	0.00302	0.0498	CbGeAlD
Mepivacaine—SCN3A—lung—hematologic cancer	0.00276	0.0454	CbGeAlD
Mepivacaine—SCN9A—lymph node—hematologic cancer	0.00272	0.0447	CbGeAlD
Mepivacaine—SCN3A—testis—hematologic cancer	0.0026	0.0428	CbGeAlD
Mepivacaine—SCN10A—lymph node—hematologic cancer	0.00207	0.034	CbGeAlD
Mepivacaine—SCN3A—lymph node—hematologic cancer	0.00189	0.031	CbGeAlD
Mepivacaine—Nausea—Hydroxyurea—hematologic cancer	0.000318	0.000469	CcSEcCtD
Mepivacaine—Vomiting—Bortezomib—hematologic cancer	0.000318	0.000469	CcSEcCtD
Mepivacaine—Hypersensitivity—Alitretinoin—hematologic cancer	0.000316	0.000466	CcSEcCtD
Mepivacaine—Vomiting—Bleomycin—hematologic cancer	0.000316	0.000465	CcSEcCtD
Mepivacaine—Drowsiness—Methotrexate—hematologic cancer	0.000315	0.000464	CcSEcCtD
Mepivacaine—Headache—Bortezomib—hematologic cancer	0.000313	0.000462	CcSEcCtD
Mepivacaine—Hypotension—Etoposide—hematologic cancer	0.000313	0.000461	CcSEcCtD
Mepivacaine—Hypersensitivity—Ifosfamide—hematologic cancer	0.000313	0.00046	CcSEcCtD
Mepivacaine—Asthenia—Carmustine—hematologic cancer	0.000311	0.000458	CcSEcCtD
Mepivacaine—Vomiting—Vinorelbine—hematologic cancer	0.000311	0.000458	CcSEcCtD
Mepivacaine—Body temperature increased—Gemcitabine—hematologic cancer	0.00031	0.000457	CcSEcCtD
Mepivacaine—Angioedema—Betamethasone—hematologic cancer	0.000309	0.000455	CcSEcCtD
Mepivacaine—Angioedema—Dexamethasone—hematologic cancer	0.000309	0.000455	CcSEcCtD
Mepivacaine—Dizziness—Thiotepa—hematologic cancer	0.000308	0.000454	CcSEcCtD
Mepivacaine—Asthenia—Alitretinoin—hematologic cancer	0.000308	0.000454	CcSEcCtD
Mepivacaine—Headache—Vinorelbine—hematologic cancer	0.000306	0.000451	CcSEcCtD
Mepivacaine—Hypersensitivity—Vincristine—hematologic cancer	0.000305	0.000449	CcSEcCtD
Mepivacaine—Asthenia—Ifosfamide—hematologic cancer	0.000304	0.000448	CcSEcCtD
Mepivacaine—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000304	0.000448	CcSEcCtD
Mepivacaine—Oedema—Triamcinolone—hematologic cancer	0.000304	0.000448	CcSEcCtD
Mepivacaine—Pruritus—Alitretinoin—hematologic cancer	0.000304	0.000447	CcSEcCtD
Mepivacaine—Syncope—Betamethasone—hematologic cancer	0.000303	0.000446	CcSEcCtD
Mepivacaine—Syncope—Dexamethasone—hematologic cancer	0.000303	0.000446	CcSEcCtD
Mepivacaine—Sweating—Methotrexate—hematologic cancer	0.000302	0.000444	CcSEcCtD
Mepivacaine—Paraesthesia—Etoposide—hematologic cancer	0.000301	0.000443	CcSEcCtD
Mepivacaine—Pruritus—Ifosfamide—hematologic cancer	0.0003	0.000442	CcSEcCtD
Mepivacaine—Shock—Triamcinolone—hematologic cancer	0.000299	0.000441	CcSEcCtD
Mepivacaine—Dizziness—Thalidomide—hematologic cancer	0.000298	0.00044	CcSEcCtD
Mepivacaine—Somnolence—Etoposide—hematologic cancer	0.000298	0.000439	CcSEcCtD
Mepivacaine—Nausea—Bortezomib—hematologic cancer	0.000297	0.000438	CcSEcCtD
Mepivacaine—Loss of consciousness—Dexamethasone—hematologic cancer	0.000297	0.000438	CcSEcCtD
Mepivacaine—Loss of consciousness—Betamethasone—hematologic cancer	0.000297	0.000438	CcSEcCtD
Mepivacaine—Hypersensitivity—Irinotecan—hematologic cancer	0.000297	0.000437	CcSEcCtD
Mepivacaine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000297	0.000437	CcSEcCtD
Mepivacaine—Asthenia—Vincristine—hematologic cancer	0.000297	0.000437	CcSEcCtD
Mepivacaine—Paraesthesia—Prednisolone—hematologic cancer	0.000297	0.000437	CcSEcCtD
Mepivacaine—Tachycardia—Triamcinolone—hematologic cancer	0.000297	0.000437	CcSEcCtD
Mepivacaine—Vomiting—Thiotepa—hematologic cancer	0.000297	0.000437	CcSEcCtD
Mepivacaine—Nausea—Bleomycin—hematologic cancer	0.000295	0.000434	CcSEcCtD
Mepivacaine—Drowsiness—Epirubicin—hematologic cancer	0.000295	0.000434	CcSEcCtD
Mepivacaine—Erythema—Prednisone—hematologic cancer	0.000294	0.000434	CcSEcCtD
Mepivacaine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000294	0.000433	CcSEcCtD
Mepivacaine—Convulsion—Dexamethasone—hematologic cancer	0.000293	0.000431	CcSEcCtD
Mepivacaine—Convulsion—Betamethasone—hematologic cancer	0.000293	0.000431	CcSEcCtD
Mepivacaine—Headache—Thiotepa—hematologic cancer	0.000292	0.000431	CcSEcCtD
Mepivacaine—Hypertension—Betamethasone—hematologic cancer	0.000292	0.00043	CcSEcCtD
Mepivacaine—Hypertension—Dexamethasone—hematologic cancer	0.000292	0.00043	CcSEcCtD
Mepivacaine—Nausea—Vinorelbine—hematologic cancer	0.00029	0.000427	CcSEcCtD
Mepivacaine—Body temperature increased—Cisplatin—hematologic cancer	0.000289	0.000426	CcSEcCtD
Mepivacaine—Asthenia—Mitoxantrone—hematologic cancer	0.000289	0.000426	CcSEcCtD
Mepivacaine—Asthenia—Irinotecan—hematologic cancer	0.000289	0.000426	CcSEcCtD
Mepivacaine—Vomiting—Thalidomide—hematologic cancer	0.000287	0.000423	CcSEcCtD
Mepivacaine—Anxiety—Dexamethasone—hematologic cancer	0.000287	0.000422	CcSEcCtD
Mepivacaine—Anxiety—Betamethasone—hematologic cancer	0.000287	0.000422	CcSEcCtD
Mepivacaine—Dizziness—Carmustine—hematologic cancer	0.000287	0.000422	CcSEcCtD
Mepivacaine—Dizziness—Alitretinoin—hematologic cancer	0.000284	0.000418	CcSEcCtD
Mepivacaine—Headache—Thalidomide—hematologic cancer	0.000283	0.000416	CcSEcCtD
Mepivacaine—Sweating—Epirubicin—hematologic cancer	0.000282	0.000416	CcSEcCtD
Mepivacaine—Asthenia—Gemcitabine—hematologic cancer	0.000282	0.000415	CcSEcCtD
Mepivacaine—Dizziness—Ifosfamide—hematologic cancer	0.000281	0.000413	CcSEcCtD
Mepivacaine—Pruritus—Gemcitabine—hematologic cancer	0.000278	0.000409	CcSEcCtD
Mepivacaine—Vision blurred—Prednisone—hematologic cancer	0.000277	0.000409	CcSEcCtD
Mepivacaine—Nausea—Thiotepa—hematologic cancer	0.000277	0.000408	CcSEcCtD
Mepivacaine—Oedema—Dexamethasone—hematologic cancer	0.000276	0.000406	CcSEcCtD
Mepivacaine—Oedema—Betamethasone—hematologic cancer	0.000276	0.000406	CcSEcCtD
Mepivacaine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000276	0.000406	CcSEcCtD
Mepivacaine—Anaphylactic shock—Betamethasone—hematologic cancer	0.000276	0.000406	CcSEcCtD
Mepivacaine—Vomiting—Carmustine—hematologic cancer	0.000276	0.000406	CcSEcCtD
Mepivacaine—Dizziness—Vincristine—hematologic cancer	0.000274	0.000403	CcSEcCtD
Mepivacaine—Vomiting—Alitretinoin—hematologic cancer	0.000273	0.000402	CcSEcCtD
Mepivacaine—Paraesthesia—Triamcinolone—hematologic cancer	0.000273	0.000402	CcSEcCtD
Mepivacaine—Drowsiness—Doxorubicin—hematologic cancer	0.000273	0.000401	CcSEcCtD
Mepivacaine—Headache—Carmustine—hematologic cancer	0.000271	0.0004	CcSEcCtD
Mepivacaine—Shock—Betamethasone—hematologic cancer	0.000271	0.0004	CcSEcCtD
Mepivacaine—Shock—Dexamethasone—hematologic cancer	0.000271	0.0004	CcSEcCtD
Mepivacaine—Agitation—Prednisone—hematologic cancer	0.00027	0.000398	CcSEcCtD
Mepivacaine—Vomiting—Ifosfamide—hematologic cancer	0.00027	0.000397	CcSEcCtD
Mepivacaine—Hypersensitivity—Cisplatin—hematologic cancer	0.000269	0.000397	CcSEcCtD
Mepivacaine—Tachycardia—Betamethasone—hematologic cancer	0.000269	0.000397	CcSEcCtD
Mepivacaine—Tachycardia—Dexamethasone—hematologic cancer	0.000269	0.000397	CcSEcCtD
Mepivacaine—Bradycardia—Epirubicin—hematologic cancer	0.000269	0.000397	CcSEcCtD
Mepivacaine—Headache—Alitretinoin—hematologic cancer	0.000269	0.000396	CcSEcCtD
Mepivacaine—Angioedema—Prednisone—hematologic cancer	0.000269	0.000396	CcSEcCtD
Mepivacaine—Nausea—Thalidomide—hematologic cancer	0.000268	0.000395	CcSEcCtD
Mepivacaine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000267	0.000393	CcSEcCtD
Mepivacaine—Hyperhidrosis—Betamethasone—hematologic cancer	0.000267	0.000393	CcSEcCtD
Mepivacaine—Dizziness—Irinotecan—hematologic cancer	0.000266	0.000392	CcSEcCtD
Mepivacaine—Urticaria—Etoposide—hematologic cancer	0.000266	0.000392	CcSEcCtD
Mepivacaine—Body temperature increased—Etoposide—hematologic cancer	0.000265	0.00039	CcSEcCtD
Mepivacaine—Syncope—Prednisone—hematologic cancer	0.000264	0.000389	CcSEcCtD
Mepivacaine—Tinnitus—Methotrexate—hematologic cancer	0.000263	0.000388	CcSEcCtD
Mepivacaine—Vomiting—Vincristine—hematologic cancer	0.000263	0.000387	CcSEcCtD
Mepivacaine—Urticaria—Prednisolone—hematologic cancer	0.000263	0.000387	CcSEcCtD
Mepivacaine—Asthenia—Cisplatin—hematologic cancer	0.000262	0.000387	CcSEcCtD
Mepivacaine—Sweating—Doxorubicin—hematologic cancer	0.000261	0.000385	CcSEcCtD
Mepivacaine—Headache—Vincristine—hematologic cancer	0.000259	0.000382	CcSEcCtD
Mepivacaine—Loss of consciousness—Prednisone—hematologic cancer	0.000259	0.000381	CcSEcCtD
Mepivacaine—Hypotension—Betamethasone—hematologic cancer	0.000258	0.00038	CcSEcCtD
Mepivacaine—Hypotension—Dexamethasone—hematologic cancer	0.000258	0.00038	CcSEcCtD
Mepivacaine—Nausea—Carmustine—hematologic cancer	0.000257	0.000379	CcSEcCtD
Mepivacaine—Vomiting—Irinotecan—hematologic cancer	0.000256	0.000377	CcSEcCtD
Mepivacaine—Vomiting—Mitoxantrone—hematologic cancer	0.000256	0.000377	CcSEcCtD
Mepivacaine—Nausea—Alitretinoin—hematologic cancer	0.000255	0.000376	CcSEcCtD
Mepivacaine—Convulsion—Prednisone—hematologic cancer	0.000255	0.000376	CcSEcCtD
Mepivacaine—Hypertension—Prednisone—hematologic cancer	0.000254	0.000374	CcSEcCtD
Mepivacaine—Chills—Methotrexate—hematologic cancer	0.000253	0.000373	CcSEcCtD
Mepivacaine—Headache—Mitoxantrone—hematologic cancer	0.000252	0.000372	CcSEcCtD
Mepivacaine—Headache—Irinotecan—hematologic cancer	0.000252	0.000372	CcSEcCtD
Mepivacaine—Nausea—Ifosfamide—hematologic cancer	0.000252	0.000371	CcSEcCtD
Mepivacaine—Anxiety—Prednisone—hematologic cancer	0.00025	0.000368	CcSEcCtD
Mepivacaine—Vomiting—Gemcitabine—hematologic cancer	0.00025	0.000368	CcSEcCtD
Mepivacaine—Bradycardia—Doxorubicin—hematologic cancer	0.000249	0.000367	CcSEcCtD
Mepivacaine—Paraesthesia—Dexamethasone—hematologic cancer	0.000248	0.000365	CcSEcCtD
Mepivacaine—Paraesthesia—Betamethasone—hematologic cancer	0.000248	0.000365	CcSEcCtD
Mepivacaine—Hypersensitivity—Etoposide—hematologic cancer	0.000247	0.000364	CcSEcCtD
Mepivacaine—Tinnitus—Epirubicin—hematologic cancer	0.000247	0.000363	CcSEcCtD
Mepivacaine—Erythema—Methotrexate—hematologic cancer	0.000246	0.000362	CcSEcCtD
Mepivacaine—Headache—Gemcitabine—hematologic cancer	0.000246	0.000362	CcSEcCtD
Mepivacaine—Nausea—Vincristine—hematologic cancer	0.000246	0.000362	CcSEcCtD
Mepivacaine—Hypersensitivity—Prednisolone—hematologic cancer	0.000244	0.000359	CcSEcCtD
Mepivacaine—Urticaria—Triamcinolone—hematologic cancer	0.000241	0.000356	CcSEcCtD
Mepivacaine—Asthenia—Etoposide—hematologic cancer	0.00024	0.000354	CcSEcCtD
Mepivacaine—Body temperature increased—Triamcinolone—hematologic cancer	0.00024	0.000354	CcSEcCtD
Mepivacaine—Anaphylactic shock—Prednisone—hematologic cancer	0.00024	0.000354	CcSEcCtD
Mepivacaine—Oedema—Prednisone—hematologic cancer	0.00024	0.000354	CcSEcCtD
Mepivacaine—Nausea—Irinotecan—hematologic cancer	0.000239	0.000353	CcSEcCtD
Mepivacaine—Nausea—Mitoxantrone—hematologic cancer	0.000239	0.000353	CcSEcCtD
Mepivacaine—Back pain—Methotrexate—hematologic cancer	0.000238	0.00035	CcSEcCtD
Mepivacaine—Chills—Epirubicin—hematologic cancer	0.000237	0.000349	CcSEcCtD
Mepivacaine—Pruritus—Etoposide—hematologic cancer	0.000237	0.000349	CcSEcCtD
Mepivacaine—Shock—Prednisone—hematologic cancer	0.000236	0.000348	CcSEcCtD
Mepivacaine—Tachycardia—Prednisone—hematologic cancer	0.000234	0.000345	CcSEcCtD
Mepivacaine—Nausea—Gemcitabine—hematologic cancer	0.000233	0.000343	CcSEcCtD
Mepivacaine—Vomiting—Cisplatin—hematologic cancer	0.000233	0.000343	CcSEcCtD
Mepivacaine—Hyperhidrosis—Prednisone—hematologic cancer	0.000232	0.000342	CcSEcCtD
Mepivacaine—Vision blurred—Methotrexate—hematologic cancer	0.000232	0.000341	CcSEcCtD
Mepivacaine—Erythema—Epirubicin—hematologic cancer	0.00023	0.000339	CcSEcCtD
Mepivacaine—Tinnitus—Doxorubicin—hematologic cancer	0.000228	0.000336	CcSEcCtD
Mepivacaine—Tension—Epirubicin—hematologic cancer	0.000226	0.000333	CcSEcCtD
Mepivacaine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000224	0.00033	CcSEcCtD
Mepivacaine—Nervousness—Epirubicin—hematologic cancer	0.000224	0.000329	CcSEcCtD
Mepivacaine—Back pain—Epirubicin—hematologic cancer	0.000223	0.000328	CcSEcCtD
Mepivacaine—Dizziness—Etoposide—hematologic cancer	0.000222	0.000326	CcSEcCtD
Mepivacaine—Chills—Doxorubicin—hematologic cancer	0.00022	0.000323	CcSEcCtD
Mepivacaine—Urticaria—Betamethasone—hematologic cancer	0.000219	0.000323	CcSEcCtD
Mepivacaine—Urticaria—Dexamethasone—hematologic cancer	0.000219	0.000323	CcSEcCtD
Mepivacaine—Dizziness—Prednisolone—hematologic cancer	0.000219	0.000322	CcSEcCtD
Mepivacaine—Asthenia—Triamcinolone—hematologic cancer	0.000218	0.000321	CcSEcCtD
Mepivacaine—Body temperature increased—Betamethasone—hematologic cancer	0.000218	0.000321	CcSEcCtD
Mepivacaine—Body temperature increased—Dexamethasone—hematologic cancer	0.000218	0.000321	CcSEcCtD
Mepivacaine—Nausea—Cisplatin—hematologic cancer	0.000217	0.00032	CcSEcCtD
Mepivacaine—Vision blurred—Epirubicin—hematologic cancer	0.000217	0.00032	CcSEcCtD
Mepivacaine—Paraesthesia—Prednisone—hematologic cancer	0.000216	0.000318	CcSEcCtD
Mepivacaine—Pruritus—Triamcinolone—hematologic cancer	0.000215	0.000317	CcSEcCtD
Mepivacaine—Convulsion—Methotrexate—hematologic cancer	0.000213	0.000314	CcSEcCtD
Mepivacaine—Vomiting—Etoposide—hematologic cancer	0.000213	0.000314	CcSEcCtD
Mepivacaine—Erythema—Doxorubicin—hematologic cancer	0.000213	0.000314	CcSEcCtD
Mepivacaine—Agitation—Epirubicin—hematologic cancer	0.000212	0.000312	CcSEcCtD
Mepivacaine—Headache—Etoposide—hematologic cancer	0.00021	0.000309	CcSEcCtD
Mepivacaine—Tension—Doxorubicin—hematologic cancer	0.000209	0.000308	CcSEcCtD
Mepivacaine—Headache—Prednisolone—hematologic cancer	0.000207	0.000305	CcSEcCtD
Mepivacaine—Nervousness—Doxorubicin—hematologic cancer	0.000207	0.000305	CcSEcCtD
Mepivacaine—Syncope—Epirubicin—hematologic cancer	0.000206	0.000304	CcSEcCtD
Mepivacaine—Back pain—Doxorubicin—hematologic cancer	0.000206	0.000303	CcSEcCtD
Mepivacaine—Loss of consciousness—Epirubicin—hematologic cancer	0.000202	0.000298	CcSEcCtD
Mepivacaine—Dizziness—Triamcinolone—hematologic cancer	0.000201	0.000296	CcSEcCtD
Mepivacaine—Anaphylactic shock—Methotrexate—hematologic cancer	0.000201	0.000296	CcSEcCtD
Mepivacaine—Vision blurred—Doxorubicin—hematologic cancer	0.000201	0.000296	CcSEcCtD
Mepivacaine—Convulsion—Epirubicin—hematologic cancer	0.000199	0.000294	CcSEcCtD
Mepivacaine—Nausea—Etoposide—hematologic cancer	0.000199	0.000293	CcSEcCtD
Mepivacaine—Hypertension—Epirubicin—hematologic cancer	0.000199	0.000293	CcSEcCtD
Mepivacaine—Asthenia—Dexamethasone—hematologic cancer	0.000198	0.000291	CcSEcCtD
Mepivacaine—Asthenia—Betamethasone—hematologic cancer	0.000198	0.000291	CcSEcCtD
Mepivacaine—Nausea—Prednisolone—hematologic cancer	0.000196	0.000289	CcSEcCtD
Mepivacaine—Agitation—Doxorubicin—hematologic cancer	0.000196	0.000288	CcSEcCtD
Mepivacaine—Anxiety—Epirubicin—hematologic cancer	0.000195	0.000288	CcSEcCtD
Mepivacaine—Pruritus—Dexamethasone—hematologic cancer	0.000195	0.000287	CcSEcCtD
Mepivacaine—Pruritus—Betamethasone—hematologic cancer	0.000195	0.000287	CcSEcCtD
Mepivacaine—Hyperhidrosis—Methotrexate—hematologic cancer	0.000194	0.000286	CcSEcCtD
Mepivacaine—Vomiting—Triamcinolone—hematologic cancer	0.000193	0.000285	CcSEcCtD
Mepivacaine—Syncope—Doxorubicin—hematologic cancer	0.000191	0.000281	CcSEcCtD
Mepivacaine—Urticaria—Prednisone—hematologic cancer	0.000191	0.000281	CcSEcCtD
Mepivacaine—Headache—Triamcinolone—hematologic cancer	0.00019	0.000281	CcSEcCtD
Mepivacaine—Body temperature increased—Prednisone—hematologic cancer	0.00019	0.00028	CcSEcCtD
Mepivacaine—Oedema—Epirubicin—hematologic cancer	0.000188	0.000277	CcSEcCtD
Mepivacaine—Anaphylactic shock—Epirubicin—hematologic cancer	0.000188	0.000277	CcSEcCtD
Mepivacaine—Hypotension—Methotrexate—hematologic cancer	0.000188	0.000276	CcSEcCtD
Mepivacaine—Loss of consciousness—Doxorubicin—hematologic cancer	0.000187	0.000276	CcSEcCtD
Mepivacaine—Shock—Epirubicin—hematologic cancer	0.000185	0.000272	CcSEcCtD
Mepivacaine—Convulsion—Doxorubicin—hematologic cancer	0.000185	0.000272	CcSEcCtD
Mepivacaine—Hypertension—Doxorubicin—hematologic cancer	0.000184	0.000271	CcSEcCtD
Mepivacaine—Tachycardia—Epirubicin—hematologic cancer	0.000183	0.00027	CcSEcCtD
Mepivacaine—Dizziness—Betamethasone—hematologic cancer	0.000182	0.000269	CcSEcCtD
Mepivacaine—Dizziness—Dexamethasone—hematologic cancer	0.000182	0.000269	CcSEcCtD
Mepivacaine—Hyperhidrosis—Epirubicin—hematologic cancer	0.000182	0.000268	CcSEcCtD
Mepivacaine—Anxiety—Doxorubicin—hematologic cancer	0.000181	0.000266	CcSEcCtD
Mepivacaine—Nausea—Triamcinolone—hematologic cancer	0.000181	0.000266	CcSEcCtD
Mepivacaine—Paraesthesia—Methotrexate—hematologic cancer	0.00018	0.000266	CcSEcCtD
Mepivacaine—Somnolence—Methotrexate—hematologic cancer	0.000178	0.000263	CcSEcCtD
Mepivacaine—Hypersensitivity—Prednisone—hematologic cancer	0.000177	0.000261	CcSEcCtD
Mepivacaine—Hypotension—Epirubicin—hematologic cancer	0.000176	0.000259	CcSEcCtD
Mepivacaine—Vomiting—Betamethasone—hematologic cancer	0.000175	0.000258	CcSEcCtD
Mepivacaine—Vomiting—Dexamethasone—hematologic cancer	0.000175	0.000258	CcSEcCtD
Mepivacaine—Oedema—Doxorubicin—hematologic cancer	0.000174	0.000256	CcSEcCtD
Mepivacaine—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000174	0.000256	CcSEcCtD
Mepivacaine—Headache—Dexamethasone—hematologic cancer	0.000173	0.000255	CcSEcCtD
Mepivacaine—Headache—Betamethasone—hematologic cancer	0.000173	0.000255	CcSEcCtD
Mepivacaine—Asthenia—Prednisone—hematologic cancer	0.000172	0.000254	CcSEcCtD
Mepivacaine—Shock—Doxorubicin—hematologic cancer	0.000171	0.000252	CcSEcCtD
Mepivacaine—Pruritus—Prednisone—hematologic cancer	0.00017	0.00025	CcSEcCtD
Mepivacaine—Tachycardia—Doxorubicin—hematologic cancer	0.00017	0.00025	CcSEcCtD
Mepivacaine—Paraesthesia—Epirubicin—hematologic cancer	0.000169	0.000248	CcSEcCtD
Mepivacaine—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000168	0.000248	CcSEcCtD
Mepivacaine—Somnolence—Epirubicin—hematologic cancer	0.000167	0.000246	CcSEcCtD
Mepivacaine—Nausea—Betamethasone—hematologic cancer	0.000164	0.000241	CcSEcCtD
Mepivacaine—Nausea—Dexamethasone—hematologic cancer	0.000164	0.000241	CcSEcCtD
Mepivacaine—Hypotension—Doxorubicin—hematologic cancer	0.000162	0.000239	CcSEcCtD
Mepivacaine—Urticaria—Methotrexate—hematologic cancer	0.000159	0.000235	CcSEcCtD
Mepivacaine—Dizziness—Prednisone—hematologic cancer	0.000159	0.000234	CcSEcCtD
Mepivacaine—Body temperature increased—Methotrexate—hematologic cancer	0.000159	0.000234	CcSEcCtD
Mepivacaine—Paraesthesia—Doxorubicin—hematologic cancer	0.000156	0.00023	CcSEcCtD
Mepivacaine—Somnolence—Doxorubicin—hematologic cancer	0.000155	0.000228	CcSEcCtD
Mepivacaine—Vomiting—Prednisone—hematologic cancer	0.000153	0.000225	CcSEcCtD
Mepivacaine—Headache—Prednisone—hematologic cancer	0.00015	0.000222	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—CDK4—hematologic cancer	0.00015	0.000575	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MET—hematologic cancer	0.00015	0.000575	CbGpPWpGaD
Mepivacaine—Urticaria—Epirubicin—hematologic cancer	0.000149	0.00022	CcSEcCtD
Mepivacaine—Body temperature increased—Epirubicin—hematologic cancer	0.000148	0.000219	CcSEcCtD
Mepivacaine—Hypersensitivity—Methotrexate—hematologic cancer	0.000148	0.000218	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—FGF2—hematologic cancer	0.000147	0.000564	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—JAK2—hematologic cancer	0.000147	0.000563	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—JAK2—hematologic cancer	0.000147	0.000563	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—VEGFA—hematologic cancer	0.000146	0.000561	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MAPK14—hematologic cancer	0.000145	0.000559	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HSP90AA1—hematologic cancer	0.000145	0.000557	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—NRAS—hematologic cancer	0.000144	0.000554	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—NOTCH1—hematologic cancer	0.000144	0.000554	CbGpPWpGaD
Mepivacaine—Asthenia—Methotrexate—hematologic cancer	0.000144	0.000212	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—CDK4—hematologic cancer	0.000143	0.00055	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MET—hematologic cancer	0.000143	0.00055	CbGpPWpGaD
Mepivacaine—Nausea—Prednisone—hematologic cancer	0.000143	0.00021	CcSEcCtD
Mepivacaine—Pruritus—Methotrexate—hematologic cancer	0.000142	0.000209	CcSEcCtD
Mepivacaine—SCN10A—Axon guidance—JAK2—hematologic cancer	0.000141	0.000543	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—JAK2—hematologic cancer	0.000141	0.000543	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—JAK2—hematologic cancer	0.000141	0.00054	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAPK14—hematologic cancer	0.00014	0.000537	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MAPK14—hematologic cancer	0.00014	0.000537	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—EP300—hematologic cancer	0.00014	0.000536	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—PTPN11—hematologic cancer	0.000139	0.000532	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Epirubicin—hematologic cancer	0.000138	0.000204	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—MAPK3—hematologic cancer	0.000138	0.000531	CbGpPWpGaD
Mepivacaine—Urticaria—Doxorubicin—hematologic cancer	0.000138	0.000203	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—NOTCH1—hematologic cancer	0.000138	0.00053	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CDK4—hematologic cancer	0.000138	0.000529	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CDK4—hematologic cancer	0.000138	0.000529	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MET—hematologic cancer	0.000138	0.000529	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MET—hematologic cancer	0.000138	0.000529	CbGpPWpGaD
Mepivacaine—Body temperature increased—Doxorubicin—hematologic cancer	0.000137	0.000202	CcSEcCtD
Mepivacaine—Asthenia—Epirubicin—hematologic cancer	0.000135	0.000199	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—MAPK14—hematologic cancer	0.000135	0.000517	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAPK14—hematologic cancer	0.000135	0.000517	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CREB1—hematologic cancer	0.000134	0.000515	CbGpPWpGaD
Mepivacaine—Pruritus—Epirubicin—hematologic cancer	0.000133	0.000196	CcSEcCtD
Mepivacaine—SCN1A—Developmental Biology—CDK4—hematologic cancer	0.000133	0.00051	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CDK4—hematologic cancer	0.000133	0.00051	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MET—hematologic cancer	0.000133	0.00051	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MET—hematologic cancer	0.000133	0.00051	CbGpPWpGaD
Mepivacaine—Dizziness—Methotrexate—hematologic cancer	0.000133	0.000196	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—NOTCH1—hematologic cancer	0.000133	0.000509	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NOTCH1—hematologic cancer	0.000133	0.000509	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PTPN11—hematologic cancer	0.000133	0.000509	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	0.000132	0.000507	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6R—hematologic cancer	0.000131	0.000503	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—GRB2—hematologic cancer	0.000131	0.000503	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MET—hematologic cancer	0.000131	0.000502	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CREBBP—hematologic cancer	0.000131	0.000502	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CREB1—hematologic cancer	0.000128	0.000493	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Doxorubicin—hematologic cancer	0.000128	0.000189	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—NOTCH1—hematologic cancer	0.000128	0.000491	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NOTCH1—hematologic cancer	0.000128	0.000491	CbGpPWpGaD
Mepivacaine—Vomiting—Methotrexate—hematologic cancer	0.000128	0.000188	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—PTPN11—hematologic cancer	0.000127	0.000489	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PTPN11—hematologic cancer	0.000127	0.000489	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ABL1—hematologic cancer	0.000126	0.000483	CbGpPWpGaD
Mepivacaine—Headache—Methotrexate—hematologic cancer	0.000126	0.000185	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—IL6R—hematologic cancer	0.000125	0.000481	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CREBBP—hematologic cancer	0.000125	0.00048	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MAP2K1—hematologic cancer	0.000125	0.000479	CbGpPWpGaD
Mepivacaine—Asthenia—Doxorubicin—hematologic cancer	0.000125	0.000184	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—KRAS—hematologic cancer	0.000124	0.000477	CbGpPWpGaD
Mepivacaine—Dizziness—Epirubicin—hematologic cancer	0.000124	0.000183	CcSEcCtD
Mepivacaine—SCN4A—Developmental Biology—CREB1—hematologic cancer	0.000123	0.000474	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CREB1—hematologic cancer	0.000123	0.000474	CbGpPWpGaD
Mepivacaine—Pruritus—Doxorubicin—hematologic cancer	0.000123	0.000181	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—PTPN11—hematologic cancer	0.000123	0.000471	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PTPN11—hematologic cancer	0.000123	0.000471	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—SRC—hematologic cancer	0.000121	0.000466	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—PTPN11—hematologic cancer	0.000121	0.000464	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6R—hematologic cancer	0.00012	0.000462	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6R—hematologic cancer	0.00012	0.000462	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CREBBP—hematologic cancer	0.00012	0.000461	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CREBBP—hematologic cancer	0.00012	0.000461	CbGpPWpGaD
Mepivacaine—Vomiting—Epirubicin—hematologic cancer	0.000119	0.000176	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—MAP2K1—hematologic cancer	0.000119	0.000458	CbGpPWpGaD
Mepivacaine—Nausea—Methotrexate—hematologic cancer	0.000119	0.000176	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—HES1—hematologic cancer	0.000119	0.000457	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CREB1—hematologic cancer	0.000119	0.000457	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CREB1—hematologic cancer	0.000119	0.000457	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—FGF2—hematologic cancer	0.000119	0.000456	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NCOR1—hematologic cancer	0.000118	0.000454	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—VEGFA—hematologic cancer	0.000118	0.000454	CbGpPWpGaD
Mepivacaine—Headache—Epirubicin—hematologic cancer	0.000118	0.000173	CcSEcCtD
Mepivacaine—SCN5A—Axon guidance—CREB1—hematologic cancer	0.000117	0.00045	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—NRAS—hematologic cancer	0.000117	0.000448	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—SRC—hematologic cancer	0.000116	0.000446	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6R—hematologic cancer	0.000116	0.000446	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6R—hematologic cancer	0.000116	0.000446	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CREBBP—hematologic cancer	0.000116	0.000445	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CREBBP—hematologic cancer	0.000116	0.000445	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FOXO1—hematologic cancer	0.000115	0.000443	CbGpPWpGaD
Mepivacaine—Dizziness—Doxorubicin—hematologic cancer	0.000115	0.000169	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—MAP2K1—hematologic cancer	0.000115	0.00044	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAP2K1—hematologic cancer	0.000115	0.00044	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6R—hematologic cancer	0.000114	0.000439	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—JAK2—hematologic cancer	0.000114	0.000437	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—FGF2—hematologic cancer	0.000114	0.000436	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—hematologic cancer	0.000113	0.000435	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—VEGFA—hematologic cancer	0.000113	0.000434	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—JAK1—hematologic cancer	0.000113	0.000434	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MAPK3—hematologic cancer	0.000112	0.000429	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—NRAS—hematologic cancer	0.000112	0.000429	CbGpPWpGaD
Mepivacaine—Nausea—Epirubicin—hematologic cancer	0.000112	0.000164	CcSEcCtD
Mepivacaine—SCN2A—Axon guidance—SRC—hematologic cancer	0.000112	0.000428	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—SRC—hematologic cancer	0.000112	0.000428	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MAP2K1—hematologic cancer	0.000111	0.000425	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAP2K1—hematologic cancer	0.000111	0.000425	CbGpPWpGaD
Mepivacaine—Vomiting—Doxorubicin—hematologic cancer	0.000111	0.000163	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—EP300—hematologic cancer	0.00011	0.000423	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—FGF2—hematologic cancer	0.000109	0.000419	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—FGF2—hematologic cancer	0.000109	0.000419	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MAP2K1—hematologic cancer	0.000109	0.000418	CbGpPWpGaD
Mepivacaine—Headache—Doxorubicin—hematologic cancer	0.000109	0.00016	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—JAK2—hematologic cancer	0.000109	0.000418	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—VEGFA—hematologic cancer	0.000109	0.000417	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—VEGFA—hematologic cancer	0.000109	0.000417	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—SRC—hematologic cancer	0.000108	0.000413	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—SRC—hematologic cancer	0.000108	0.000413	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—NRAS—hematologic cancer	0.000107	0.000412	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—NRAS—hematologic cancer	0.000107	0.000412	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—SRC—hematologic cancer	0.000107	0.000411	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MAPK3—hematologic cancer	0.000107	0.000411	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—HRAS—hematologic cancer	0.000106	0.000406	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—FGF2—hematologic cancer	0.000105	0.000404	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—FGF2—hematologic cancer	0.000105	0.000404	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—VEGFA—hematologic cancer	0.000105	0.000402	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—VEGFA—hematologic cancer	0.000105	0.000402	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—JAK2—hematologic cancer	0.000105	0.000401	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—JAK2—hematologic cancer	0.000105	0.000401	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—VEGFA—hematologic cancer	0.000104	0.0004	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—NRAS—hematologic cancer	0.000103	0.000397	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—NRAS—hematologic cancer	0.000103	0.000397	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—STAT3—hematologic cancer	0.000103	0.000396	CbGpPWpGaD
Mepivacaine—Nausea—Doxorubicin—hematologic cancer	0.000103	0.000152	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—NRAS—hematologic cancer	0.000103	0.000396	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MAPK3—hematologic cancer	0.000103	0.000395	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MAPK3—hematologic cancer	0.000103	0.000395	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—IL6—hematologic cancer	0.000101	0.000388	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—JAK2—hematologic cancer	0.000101	0.000387	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—JAK2—hematologic cancer	0.000101	0.000387	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—KRAS—hematologic cancer	0.0001	0.000386	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—JAK2—hematologic cancer	9.93e-05	0.000381	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MAPK3—hematologic cancer	9.91e-05	0.00038	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MAPK3—hematologic cancer	9.91e-05	0.00038	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MAPK3—hematologic cancer	9.86e-05	0.000379	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—KRAS—hematologic cancer	9.61e-05	0.000369	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TGFB1—hematologic cancer	9.57e-05	0.000368	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAPK14—hematologic cancer	9.47e-05	0.000364	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MET—hematologic cancer	9.33e-05	0.000358	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CDK4—hematologic cancer	9.33e-05	0.000358	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—KRAS—hematologic cancer	9.23e-05	0.000355	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—KRAS—hematologic cancer	9.23e-05	0.000355	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—hematologic cancer	9.14e-05	0.000351	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NOTCH1—hematologic cancer	8.98e-05	0.000345	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TNF—hematologic cancer	8.94e-05	0.000343	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—EP300—hematologic cancer	8.91e-05	0.000342	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—KRAS—hematologic cancer	8.9e-05	0.000342	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—KRAS—hematologic cancer	8.9e-05	0.000342	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—KRAS—hematologic cancer	8.87e-05	0.00034	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SRC—hematologic cancer	8.66e-05	0.000333	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PTPN11—hematologic cancer	8.63e-05	0.000331	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—HRAS—hematologic cancer	8.54e-05	0.000328	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—EP300—hematologic cancer	8.52e-05	0.000327	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—VEGFA—hematologic cancer	8.43e-05	0.000324	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CREB1—hematologic cancer	8.36e-05	0.000321	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—STAT3—hematologic cancer	8.35e-05	0.000321	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—NRAS—hematologic cancer	8.33e-05	0.00032	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SRC—hematologic cancer	8.28e-05	0.000318	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—EP300—hematologic cancer	8.18e-05	0.000314	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EP300—hematologic cancer	8.18e-05	0.000314	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—IL6—hematologic cancer	8.17e-05	0.000314	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—HRAS—hematologic cancer	8.17e-05	0.000314	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6R—hematologic cancer	8.16e-05	0.000313	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CREBBP—hematologic cancer	8.15e-05	0.000313	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—VEGFA—hematologic cancer	8.07e-05	0.00031	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—STAT3—hematologic cancer	7.99e-05	0.000307	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MAPK3—hematologic cancer	7.98e-05	0.000306	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—NRAS—hematologic cancer	7.97e-05	0.000306	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SRC—hematologic cancer	7.96e-05	0.000306	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SRC—hematologic cancer	7.96e-05	0.000306	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EP300—hematologic cancer	7.89e-05	0.000303	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—EP300—hematologic cancer	7.89e-05	0.000303	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—HRAS—hematologic cancer	7.85e-05	0.000301	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—HRAS—hematologic cancer	7.85e-05	0.000301	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—IL6—hematologic cancer	7.82e-05	0.0003	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAP2K1—hematologic cancer	7.77e-05	0.000299	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—VEGFA—hematologic cancer	7.75e-05	0.000298	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—VEGFA—hematologic cancer	7.75e-05	0.000298	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TGFB1—hematologic cancer	7.74e-05	0.000297	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—STAT3—hematologic cancer	7.67e-05	0.000295	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—STAT3—hematologic cancer	7.67e-05	0.000295	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SRC—hematologic cancer	7.67e-05	0.000295	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SRC—hematologic cancer	7.67e-05	0.000295	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NRAS—hematologic cancer	7.66e-05	0.000294	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NRAS—hematologic cancer	7.66e-05	0.000294	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MAPK3—hematologic cancer	7.63e-05	0.000293	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—HRAS—hematologic cancer	7.57e-05	0.000291	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—HRAS—hematologic cancer	7.57e-05	0.000291	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—SRC—hematologic cancer	7.56e-05	0.00029	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—HRAS—hematologic cancer	7.54e-05	0.000289	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—IL6—hematologic cancer	7.51e-05	0.000288	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—IL6—hematologic cancer	7.51e-05	0.000288	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—VEGFA—hematologic cancer	7.47e-05	0.000287	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—VEGFA—hematologic cancer	7.47e-05	0.000287	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TGFB1—hematologic cancer	7.4e-05	0.000284	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—STAT3—hematologic cancer	7.4e-05	0.000284	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—STAT3—hematologic cancer	7.4e-05	0.000284	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FGF2—hematologic cancer	7.39e-05	0.000284	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NRAS—hematologic cancer	7.38e-05	0.000283	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NRAS—hematologic cancer	7.38e-05	0.000283	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—VEGFA—hematologic cancer	7.36e-05	0.000283	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MAPK3—hematologic cancer	7.33e-05	0.000282	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAPK3—hematologic cancer	7.33e-05	0.000282	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—NRAS—hematologic cancer	7.27e-05	0.000279	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—IL6—hematologic cancer	7.24e-05	0.000278	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—IL6—hematologic cancer	7.24e-05	0.000278	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TNF—hematologic cancer	7.23e-05	0.000278	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—IL6—hematologic cancer	7.21e-05	0.000277	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—KRAS—hematologic cancer	7.17e-05	0.000275	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TGFB1—hematologic cancer	7.11e-05	0.000273	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TGFB1—hematologic cancer	7.11e-05	0.000273	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—JAK2—hematologic cancer	7.09e-05	0.000272	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MAPK3—hematologic cancer	7.07e-05	0.000271	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAPK3—hematologic cancer	7.07e-05	0.000271	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MAPK3—hematologic cancer	6.97e-05	0.000267	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TNF—hematologic cancer	6.91e-05	0.000265	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TGFB1—hematologic cancer	6.86e-05	0.000263	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TGFB1—hematologic cancer	6.86e-05	0.000263	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—KRAS—hematologic cancer	6.86e-05	0.000263	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—AKT1—hematologic cancer	6.65e-05	0.000256	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TNF—hematologic cancer	6.64e-05	0.000255	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TNF—hematologic cancer	6.64e-05	0.000255	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KRAS—hematologic cancer	6.59e-05	0.000253	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KRAS—hematologic cancer	6.59e-05	0.000253	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TNF—hematologic cancer	6.41e-05	0.000246	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TNF—hematologic cancer	6.41e-05	0.000246	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KRAS—hematologic cancer	6.35e-05	0.000244	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KRAS—hematologic cancer	6.35e-05	0.000244	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KRAS—hematologic cancer	6.26e-05	0.00024	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—HRAS—hematologic cancer	6.09e-05	0.000234	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6—hematologic cancer	5.83e-05	0.000224	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—HRAS—hematologic cancer	5.83e-05	0.000224	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—HRAS—hematologic cancer	5.6e-05	0.000215	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—HRAS—hematologic cancer	5.6e-05	0.000215	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6—hematologic cancer	5.58e-05	0.000214	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EP300—hematologic cancer	5.55e-05	0.000213	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HRAS—hematologic cancer	5.4e-05	0.000207	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HRAS—hematologic cancer	5.4e-05	0.000207	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SRC—hematologic cancer	5.39e-05	0.000207	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT1—hematologic cancer	5.38e-05	0.000207	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6—hematologic cancer	5.36e-05	0.000206	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6—hematologic cancer	5.36e-05	0.000206	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—HRAS—hematologic cancer	5.32e-05	0.000204	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—VEGFA—hematologic cancer	5.25e-05	0.000202	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—STAT3—hematologic cancer	5.2e-05	0.0002	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NRAS—hematologic cancer	5.19e-05	0.000199	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6—hematologic cancer	5.17e-05	0.000198	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6—hematologic cancer	5.17e-05	0.000198	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT1—hematologic cancer	5.15e-05	0.000198	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6—hematologic cancer	5.09e-05	0.000196	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAPK3—hematologic cancer	4.97e-05	0.000191	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT1—hematologic cancer	4.95e-05	0.00019	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT1—hematologic cancer	4.95e-05	0.00019	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TGFB1—hematologic cancer	4.82e-05	0.000185	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT1—hematologic cancer	4.77e-05	0.000183	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT1—hematologic cancer	4.77e-05	0.000183	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TNF—hematologic cancer	4.5e-05	0.000173	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KRAS—hematologic cancer	4.47e-05	0.000172	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HRAS—hematologic cancer	3.8e-05	0.000146	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6—hematologic cancer	3.63e-05	0.00014	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT1—hematologic cancer	3.35e-05	0.000129	CbGpPWpGaD
